Cancer

Podcast

The Atrium: Neoadjuvant Chemoimmunotherapy

September 29, 2026 | Alice Copperwheat…

In this episode of The Atrium, host Alice Copperwheat speaks with Jessica Donington, Professor of Surgery and Chief of the Section of Thoracic Surgery at the University of Chicago, Illinois, USA, about neoadjuvant chemoimmunotherapy. The...

Podcast

The Beat With Joel Dunning Ep. 177: Expert Consensus Document on LVRS for Emphysema

October 15, 2026 | Joel DunningGold ContributorSilver Commentor…

This week on The Beat, CTSNet Editor-in-Chief Joel Dunning spoke with David Waller, Chair of the EACTS Emphysema Taskforce and Director of the EACTS Fundamentals Course in Thoracic Surgery, about...

Video

Yolk Sack Tumor—Robotic Resection on a Pediatric Patient

October 13, 2026 | Bernardo Wagner…

Mediastinal and intrathoracic germ cell tumors are rare in the pediatric population, and extragonadal yolk sac tumors presenting as giant thoracic masses are rarer still. These tumors pose a dual...

Podcast

The Atrium: Neoadjuvant Chemoimmunotherapy

September 29, 2026 | Alice Copperwheat…

In this episode of The Atrium, host Alice Copperwheat speaks with Jessica Donington, Professor of Surgery and Chief of the Section of Thoracic Surgery at the University of Chicago, Illinois,...

Video

Downstaging-Driven Surgical Strategy in Locally Advanced NSCLC

September 25, 2026 | Ilaria Potenza…

The role of surgery in locally advanced non-small cell lung cancer (NSCLC) is continuously evolving with the introduction of effective neoadjuvant systemic treatments. Beyond tumor reduction, treatment response may influence...

JANS Article

Advancing the Needle on the Management of Resectable EGFR-Positive NSCLC: Is Neoadjuvant Osimertinib the Answer?

June 5, 2025 | Akshay PatelSilver Contributor

This article reviews recent efforts to evaluate the use of osimertinib, a third-generation EGFR tyrosine kinase inhibitor (TKI), in the neoadjuvant setting for patients with resectable EGFR-mutant non-small cell lung...

JANS Article

Optimizing Surgical Precision: A Comparative Study of Three-Port vs. Four-Port Robotic-Assisted Lobectomy for NSCLC

May 7, 2025 | Jade QuSilver Contributor

This retrospective analysis compared three-port and four-port robotic-assisted thoracoscopic surgery (RATS) lobectomy for non-small cell lung cancer (NSCLC)(n=121, 2020–2021). Demographics, tumor characteristics, complications, and lymph node yields were similar between...

JANS Article

Estimated Worldwide Variation and Trends in Incidence of Lung Cancer by Histological Subtype in 2022 and Over Time: A Population-Based Study

April 17, 2025 | Akshay PatelSilver Contributor

This article presents a comprehensive epidemiological analysis of lung cancer, focusing on subtype-specific patterns worldwide. Using data from GLOBOCAN 2022 and other international cancer registries, the study estimated more than...

JANS Article

Lung Cancer Screening and USPSTF Recommendations

March 6, 2025 | Erica CurcioGold Contributor

Lung cancer remains the leading cause of cancer-related deaths, and low-dose computed tomography screening can reduce mortality for high-risk individuals. In 2021, the US Preventive Services Task Force (USPSTF) expanded...

JANS Article

Why and When Do We Invasively Restage After Neoadjuvant Chemoimmunotherapy?

January 2, 2025 | Akshay PatelSilver Contributor

This article addresses the evolving role of invasive mediastinal restaging in managing resectable stage II and III NSCLC in the era of neoadjuvant chemoimmunotherapy. It emphasizes that while invasive restaging...

JANS Article

Lung Transplant Outcome From Selected Older Donors (≥70 Years) Equals Younger Donors (

January 2, 2025 | Akshay PatelSilver Contributor

This study evaluates the outcomes of bilateral lung transplantation (LTx) using grafts from donors aged 70 years or older, compared with those from younger donors. Conducted at a single center...

JANS Article

The Efficacy of Loco-Regional Ropivacaine Analgesia Via Intercostal Catheters After Lung Resection: A Randomized, Double-Blind, Placebo-Controlled, Superiority Study

November 21, 2024 | Javeria TariqBronze Contributor

Current guidelines advocate for surgically placed intercoastal catheters (ICC) for pain optimization following minimally invasive anatomic lung resection. This double-blind, randomized study aimed to determine the efficacy of loco-regional continuous...

JANS Article

Treatment Patterns and Clinical Outcomes of Patients With Resectable Non–Small Cell Lung Cancer Receiving Neoadjuvant Immunochemotherapy: A Large-Scale, Multicenter, Real-World Study (NeoR-World)

October 24, 2024 | Akshay PatelSilver Contributor

This article evaluates the effectiveness of neoadjuvant immunotherapy combined with chemotherapy (IC+Chemo) in treating non-small cell lung cancer (NSCLC). This large-scale study involved 1,092 patients from 11 medical centers and...

LOAD MORE
ADVERTISE ON CTSNET